Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081981 | 12708198 | 1 | I | 20160815 | 20160826 | 20160901 | 20160901 | EXP | GB-ABBVIE-16P-167-1716720-00 | ABBVIE | 26.00 | YR | F | Y | 70.80000 | KG | 20160901 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081981 | 12708198 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | Y | 2773178 | 50662 | 500 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127081981 | 12708198 | 1 | Tonsillitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127081981 | 12708198 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127081981 | 12708198 | Abdominal tenderness | |
| 127081981 | 12708198 | Asthma | |
| 127081981 | 12708198 | Decreased appetite | |
| 127081981 | 12708198 | Diarrhoea | |
| 127081981 | 12708198 | Dysgeusia | |
| 127081981 | 12708198 | Muscular weakness | |
| 127081981 | 12708198 | Paraesthesia | |
| 127081981 | 12708198 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127081981 | 12708198 | 1 | 20160815 | 20160817 | 0 |